White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma

Not recruiting

1 1 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Crizotinib
- Entrectinib
+4
Study on the Effectiveness of Durvalumab and Bevacizumab with TACE in Patients with Localized Liver Cancer

Not recruiting

3 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Not recruiting

3 1
Investigated diseases:
- Hypertension
Investigated drugs:
- Baxdrostat
+8
Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

Not recruiting

3 1 1
Investigated diseases:
- Dementia Alzheimer’s type
Investigated drugs:
- Semaglutide
+15
Study on the Acceptability of Pancreas Powder for Patients with Cystic Fibrosis and Pancreatic Exocrine Insufficiency

Not recruiting

1 1 1 1
Investigated diseases:
- Cystic fibrosis gastrointestinal disease
Investigated drugs:
- Pancreas Powder
Study on Colchicine for Reducing Inflammation in Patients with Stroke or TIA and Atherosclerosis

Not recruiting

2 1 1 1
Investigated diseases:
- Embolic stroke
Investigated drugs:
- Colchicine
Study of Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemotherapy and Radiation Therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer stage III
Investigated drugs:
- Atezolizumab
Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma

Not recruiting

3 1
Investigated diseases:
- Follicular lymphoma
Investigated drugs:
- Ibrutinib
+5
Continued Regorafenib Treatment for Patients with Solid Tumors from Previous Bayer Studies

Not recruiting

2 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
- Regorafenib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies